Recruiting
Phase 2

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Sponsor:

Pfizer

Code:

NCT05287126

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information